{"id":"W2898349859","doi":"10.1093/annonc/mdy282.107","title":"Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine (nab-P/G) vs FOLFIRINOX (FFX) in patients (pts) with advanced pancreatic cancer (aPC)","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Health Services","funders":"Genentech; CYTED Ciencia y Tecnología para el Desarrollo; Novocure; Celgene; Pfizer","keywords":"Medicine; Gemcitabine; FOLFIRINOX; Internal medicine; Gastroenterology; Pancreatic cancer; Chemotherapy; Chemotherapy regimen; Cancer; Surgery; Irinotecan","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01469811,0.0009691409,0.005355866,0.003379325,0.0003618216,0.002401617,0.0008991872,0.001703091,0.00382302],"category_scores_gemma":[0.03647146,0.000661804,0.009395462,0.003047461,0.000838837,0.001592463,0.0007876934,0.00128723,0.0003013489],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002809416,"about_ca_system_score_gemma":0.002544366,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001764255,"about_ca_topic_score_gemma":0.005029817,"domain_scores_codex":[0.9846035,0.0087569,0.004633419,0.0008397501,0.000940759,0.0002256984],"domain_scores_gemma":[0.9706119,0.01851271,0.008558119,0.0005216253,0.001398229,0.0003975195],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"observational","study_design_scores_codex":[0.0868417,0.0005571317,0.007110268,0.6638651,0.179052,0.0002534375,0.0004154646,0.0006156496,0.001026949,0.0004176974,0.000882317,0.05896227],"study_design_scores_gemma":[0.07474825,0.04300456,0.03239802,0.2037602,0.6285534,0.000801115,0.0008655987,0.0005308018,0.001341747,0.0009611226,0.01284779,0.0001874464],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.07492144,0.9185641,0.0003722171,0.0006367547,0.0003654323,0.00228757,0.001571025,0.00002048913,0.001261029],"genre_scores_gemma":[0.6318411,0.3566768,0.003179356,0.001859804,0.0005897845,0.003584795,0.001734277,0.00002602867,0.0005080504],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01469811,"threshold_uncertainty_score":0.07773191,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08451817346487583,"score_gpt":0.4501507874121731,"score_spread":0.3656326139472972,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}